Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Novel Causal Inference Method Estimates Treatment Effects of Contemporary Drugs in a Global Cohort of Patients with Relapsed and Refractory Mature T-Cell and NK-Cell Neoplasms

Blood (2023) 142 (Supplement 1): 1703.

https://doi.org/10.1182/blood-2023-185881

Published: 2023

Journal Articles

Impact of Therapy Sequence on Survival Outcomes Among Patients with Relapsed or Refractory Mature T and NK Cell Neoplasms: A Global Retrospective Cohort Study

Mark N Sorial, Min Jung Koh, Leora Boussi, Jessy Xinyi Han, Luke Peng, Ijeoma Julie Eche-Ugwu, Rui Duan, Matthew M. Lei, Eliana Miranda, Carlos Chiattone, Robert Stuver, Steven M. Horwitz, Maria J. Fernandez Turizo, Sean McCabe, Mwanasha Hamuza Merrill, Eric Jacobsen, Jin Seok Kim, Yu Ri Kim, Jae Yong Cho, Hasmukh Jain, Manju Sengar, Thomas Eipe, Tanuja Shet, Shambhavi Singh, Uvette Lou, Hesham Raghib, Judith Gabler, Min Ji Koh, Carrie Van Der Weyden, Miles Prince, Ramzi Hamouche, Tinatin Muradashvili, Francine M. Foss, Marianna Gentilini, Beatrice Casadei, Pier Luigi Zinzani, Takeshi Okatani, Noriaki Yoshida, Sang Eun Yoon, Won Seog Kim, Girisha Panchoo, Zainab Mohamed, Estelle Verburgh, Jackielyn Cuenca Alturas, Mubarak Al Mansour, Josie Ford, Martina Manni, Massimo Federico, Owen A. O'Connor, Maria Elena Cabrera, Enrica Marchi, Changyu Shen, Devavrat Shah, Salvia Jain

Blood (2023) 142 (Supplement 1): 3080.

https://doi.org/10.1182/blood-2023-182341

Published: 2023

Journal Articles

Incorporation of Machine Learning Tools to Predict Global Outcomes for Patients with Relapsed and Refractory Peripheral T and NK/T-Cell Lymphomas in the Contemporary Era

Blood (2022) 140 (Supplement 1): 10976–10978.

https://doi.org/10.1182/blood-2022-162944

Published: 2022

Journal Articles

TP63 Fusions Drive Enhancer Rewiring, Lymphomagenesis, and Dependence on EZH2

Blood (2022) 140 (Supplement 1): 1696–1697.

https://doi.org/10.1182/blood-2022-163368

Published: 2022

Journal Articles

Incidence of lymphoid neoplasms among atomic bomb survivors by histological subtype, 1950 to 1994

Megumu Fujihara, Ritsu Sakata, Noriaki Yoshida, Kotaro Ozasa, Dale L. Preston, Kiyohiko Mabuchi

Blood (2022) 139 (2): 217–227.

https://doi.org/10.1182/blood.2020010475

Published: 2022

Includes: Supplemental data

Journal Articles

Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions

Noriaki Yoshida, Kay Shigemori, Nicholas Donaldson, Christopher Trevisani, Nicolas A. Cordero, Kristen E. Stevenson, Xia Bu, Fumiko Arakawa, Mai Takeuchi, Koichi Ohshima, Akinori Yoda, Samuel Y. Ng, David M. Weinstock

Blood (2020) 135 (17): 1467–1471.

https://doi.org/10.1182/blood.2019001815

Published: 2020

Includes: Supplemental data

Journal Articles

Genomic Landscape of Young ATLL Patients Identifies Frequent Targetable CD28 Fusions

Noriaki Yoshida, MD PhD, Kay Shigemori, Samuel Y. Ng, MD PhD, Ajit Nirmal, PhD, Nicolas Donaldson, Nicolas Cordero, Kristen E. Stevenson, MS, Xia Bu, Mai Takeuchi, MD PhD, Koichi Ohshima, MD PhD, Akinori Yoda, PhD, David M Weinstock

Blood (2019) 134 (Supplement_1): 2760.

https://doi.org/10.1182/blood-2019-122525

Published: 2019

Journal Articles

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

Blood (2019) 133 (15): 1664–1676.

https://doi.org/10.1182/blood-2018-09-872549

Published: 2019

Includes: Supplemental data

Journal Articles

Clinicogenetic risk modeling in ATL

Noriaki Yoshida, David M. Weinstock

Blood (2018) 131 (2): 159–160.

https://doi.org/10.1182/blood-2017-11-815472

Published: 2018

Journal Articles

In Vitro andpre-Clinical In Vivo evidence Support MDMX/MDM2 As Common Vulnerabilities across TP53 -Wild-Type T-Cell Lymphomas That Are Targetable with the α-Helical p53 Stapled Peptide Alrn-6924

Raphael Koch, MD, Amanda L Christie, BS, Noriaki Yoshida, MD PhD, Samuel Y. Ng, MDPhD, Kay Shigemori, Sara N Morrow, Alexandria Van Scoyk, Steven M. Horwitz, MD, Eric Jacobsen, MD, Solimar Santiago, Jian-Guo Ren, Vincent Guerlavais, PhD, D. Allan Annis, Manuel A. Aivado, MD PhD, David M. Weinstock, MD

Blood (2017) 130 (Supplement 1): 571.

https://doi.org/10.1182/blood.V130.Suppl_1.571.571

Published: 2017

Journal Articles

Expression Pattern of Immunosurveillance-Related Antigen Is a Critical Prognostic Factor of Adult T-Cell Leukemia/Lymphoma

Naoko Asano, MD PhD, Hiroaki Miyoshi, MD PhD, Takeharu Kato, MD, Joji Shimono, MD, Noriaki Yoshida, MD PhD, Daisuke Kurita, MD, Yuya Sasaki, MD, Keisuke Kawamoto, MD, Koichi Ohshima, MD PhD, Masao Seto, MD PhD

Blood (2016) 128 (22): 4135.

https://doi.org/10.1182/blood.V128.22.4135.4135

Published: 2016

Journal Articles

PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma

Hiroaki Miyoshi, Junichi Kiyasu, Takeharu Kato, Noriaki Yoshida, Joji Shimono, Shintaro Yokoyama, Hiroaki Taniguchi, Yuya Sasaki, Daisuke Kurita, Keisuke Kawamoto, Koji Kato, Yoshitaka Imaizumi, Masao Seto, Koichi Ohshima

Blood (2016) 128 (10): 1374–1381.

https://doi.org/10.1182/blood-2016-02-698936

Published: 2016

Journal Articles

Immunohistochemical Expression Pattern of Programmed Cell Death Ligand 1 Might be Both Good and Bad Prognostic Factor in Adult T-Cell Leukemia/ Lymphoma

Miyoshi Hiroaki, MD PhD, Junichi Kiyasu, MD, Takeharu Kato, MD, Noriaki Yoshida, MD PhD, Daisuke Kurita, MD, Sasaki Yuya, MD, Koji Kato, MDPhD, Yoshitaka Imaizumi, MD PhD, Masao Seto, MD PhD, Koichi Akashi, MD PhD, Koichi Ohshima, MD PhD

Blood (2015) 126 (23): 3891.

https://doi.org/10.1182/blood.V126.23.3891.3891

Published: 2015

Journal Articles

Clinical Significance of MYC, BCL2 and BCL6 Rearrangement and Protein Expression in GCB and Non-GCB Type Diffuse Large B-Cell Lymphoma

Keisuke Kawamoto, MD, Jun Takizawa, MD, Hiroaki Miyoshi, MD, Noriaki Yoshida, MD, Yasuhiko Shibasaki, MD, Masayoshi Masuko, MD, Hirohito Sone, MD, Naoya Nakamura, MD PhD, Koichi Ohshima, MD PhD

Blood (2015) 126 (23): 1445.

https://doi.org/10.1182/blood.V126.23.1445.1445

Published: 2015

Journal Articles

STX11 Acts As a Novel Tumor Suppressor Gene in Peripheral T-Cell Lymphomas

Noriaki Yoshida, MD, Shinobu Tsuzuki, MD PhD, Kennosuke Karube, MD PhD, Miyuki Katayama, MD PhD, Taishi Takahara, MD, Shigeo Nakamura, MD PhD, Momoko Nishikori, MD, PhD, Masanori Shimoyama, MD PhD, Koichi Ohshima, MD PhD, Kunihiro Tsukasaki, MD PhD, Masao Seto, MD PhD

Blood (2014) 124 (21): 1615.

https://doi.org/10.1182/blood.V124.21.1615.1615

Published: 2014

Journal Articles

FDC Like Cell Line HK With IL-2, IL-4 and OX40 Ligand Supports The Growth Of ATLL Cells

Yoshitoyo Kagami, MD, Dai Chihara, MD, Harumi Kato, M.D, Ph.D., Noriaki Yoshida, MD, Tomohiro Kinoshita, MD, PhD, Masao Seto, MD, PhD

Blood (2013) 122 (21): 4319.

https://doi.org/10.1182/blood.V122.21.4319.4319

Published: 2013

Journal Articles

Cell Cycle Deregulation Determines Acute Transformation In Chronic Type Adult T-Cell Leukemia/Lymphoma

Noriaki Yoshida, MD, Kennosuke Karube, MD, PhD, Atae Utsunomiya, M.D., PhD, Kunihiro Tsukasaki, MD, PhD, Yoshitaka Imaizumi, MD, PhD, Naoya Taira, MD, PhD, Naokuni Uike, MD, PhD, Akira Umino, MD, Kotaro Arita, MD, Miyuki Suguro, MD, PhD, Shinobu Tsuzuki, MD, PhD, Tomohiro Kinoshita, MD, PhD, Koichi Ohshima, MD, PhD, Masao Seto, MD, PhD

Blood (2013) 122 (21): 845.

https://doi.org/10.1182/blood.V122.21.845.845

Published: 2013

Journal Articles

Identification of Multiple Subclones in Peripheral T-Cell Lymphoma, Not Otherwise Specified with Genomic Aberrations

Noriaki Yoshida, MD, Akira Umino, MD, Fang Liu, MD, PhD, Kotaro Arita, MD, Kennosuke Karube, MD, PhD, Shinobu Tsuzuki, MD, PhD, Koichi Ohshima, MD, PhD, Masao Seto, MD, PhD

Blood (2012) 120 (21): 298.

https://doi.org/10.1182/blood.V120.21.298.298

Published: 2012

Journal Articles

Treatment Results of Intensive Chemotherapy for Higher-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia Related to MDS (MDS-AML)

Taiichi Kyo, MD, Noriaki Yoshida, MD, Kouhei Kyo, MD, Takeshi Okatani, MD, Mitsuhiro Itagaki, MD, Hiromi Yuasa, MD, Koji Iwato, MD, Hideki Asaoku, MD, Yuuta Katayama, MD

Blood (2010) 116 (21): 2934.

https://doi.org/10.1182/blood.V116.21.2934.2934

Published: 2010

Journal Articles

Establishment of An HS23 Stromal Cell-Dependent Myeloma Cell Line: Fibronectin and IL-6 Are Critical for Survival

Akira Sakai, MD, PhD, Miyo Oda, PhD, Noriaki Yoshida, MD, Mitsuhiro Itagaki, MD, Koji Arihiro, MD, PhD, Akiro Kimura, MD, PhD

Blood (2010) 116 (21): 2949.

https://doi.org/10.1182/blood.V116.21.2949.2949

Published: 2010

NARROW

Novel Causal Inference Method Estimates Treatment Effects of Contemporary Drugs in a Global Cohort of Patients with Relapsed and Refractory Mature T-Cell and NK-Cell Neoplasms

Impact of Therapy Sequence on Survival Outcomes Among Patients with Relapsed or Refractory Mature T and NK Cell Neoplasms: A Global Retrospective Cohort Study

Incorporation of Machine Learning Tools to Predict Global Outcomes for Patients with Relapsed and Refractory Peripheral T and NK/T-Cell Lymphomas in the Contemporary Era

TP63 Fusions Drive Enhancer Rewiring, Lymphomagenesis, and Dependence on EZH2

Incidence of lymphoid neoplasms among atomic bomb survivors by histological subtype, 1950 to 1994

Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions

Genomic Landscape of Young ATLL Patients Identifies Frequent Targetable CD28 Fusions

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

Clinicogenetic risk modeling in ATL

In Vitro andpre-Clinical In Vivo evidence Support MDMX/MDM2 As Common Vulnerabilities across TP53 -Wild-Type T-Cell Lymphomas That Are Targetable with the α-Helical p53 Stapled Peptide Alrn-6924

Expression Pattern of Immunosurveillance-Related Antigen Is a Critical Prognostic Factor of Adult T-Cell Leukemia/Lymphoma

PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma

Immunohistochemical Expression Pattern of Programmed Cell Death Ligand 1 Might be Both Good and Bad Prognostic Factor in Adult T-Cell Leukemia/ Lymphoma

Clinical Significance of MYC, BCL2 and BCL6 Rearrangement and Protein Expression in GCB and Non-GCB Type Diffuse Large B-Cell Lymphoma

STX11 Acts As a Novel Tumor Suppressor Gene in Peripheral T-Cell Lymphomas

FDC Like Cell Line HK With IL-2, IL-4 and OX40 Ligand Supports The Growth Of ATLL Cells

Cell Cycle Deregulation Determines Acute Transformation In Chronic Type Adult T-Cell Leukemia/Lymphoma

Identification of Multiple Subclones in Peripheral T-Cell Lymphoma, Not Otherwise Specified with Genomic Aberrations

Treatment Results of Intensive Chemotherapy for Higher-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia Related to MDS (MDS-AML)

Establishment of An HS23 Stromal Cell-Dependent Myeloma Cell Line: Fibronectin and IL-6 Are Critical for Survival

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only